NFLX is at support, which has held a few times already. Although the recent news about Pfizer's vaccine had a negative impact, the company did benefit from subscriber growth during the pandemic and is in overall a good spot. I see this trade as worth taking, considering the R:R ratio but will nevertheless be cautious, as tech might continue to trend down heavily duo to the vaccine news.
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.